Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients

Epidemiologia e Psichiatria Sociale

Volumn 18, Issue 3, 2009, Pages 179-183

  Tondo, Leonardo ^a   Baldessarini, Ross J ^a  

^a Centro Bini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM DERIVATIVE; TRANQUILIZER;

BIPOLAR DISORDER; EDITORIAL; HUMAN; SUICIDE; TIME;

ANTIMANIC AGENTS; BIPOLAR DISORDER; HUMANS; LITHIUM COMPOUNDS; SUICIDE; TIME FACTORS;

EID: 75549086963     PISSN: 1121189X     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1121189x00000439     Document Type: Article

References (51)

1. Ahrens B. & Müller-Oerlinghausen B. (2001Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry 34, 132-136. (Pubitemid 32701762)
2. Akiskal H.S., Benazzi F., Perugi G. & Rihmer Z. (2005Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. Journal of Affective Disorders 85, 245-258. (Pubitemid 40386508)
3. Angst J., Angst F., Gerber-Werder R. & Gamma A. (2005Suicide in 406 mood-disorder patients with and without long-term medication: a 40-44 years follow-up. Archives of Suicide Research 9, 279-300. (Pubitemid 40977549)
4. Baldessarini R.J. & Tondo L. (2008). Lithium and suicidal risk. Bipolar Disorders 10, 114-115.
5. Baldessarini R.J. & Tondo L. (2009). Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants. Pharmacopsychiatry 42, 72-75.
6. Baldessarini R.J., Salvatore P., Tohen M., Khalsa HMK. & Hennen J. (2004). Morbidity from onset in first-episode bipolar I disorder patients: The International-300 study. Neuropsychopharmacology 29, Suppl. 1, S88.
7. Baldessarini R.J., Pompili M., Tondo L., Tsapakis E., Soldani F., Faedda G.L. & Hennen J. (2005). Antidepressants and suicidal behavior: are we hurting or helping? Clinical Neuropsychiatry 2, 73-75.
8. Baldessarini R.J., Tondo L., Davis P., Pompili M., Goodwin F.K. & Hennen J. (2006). Decreased suicidal risk during long-term lithium treatment: meta-analysis. Bipolar Disorders 8, 625-639.
9. Baldessarini R.J., Tondo L., Strombom L, Dominguez S., Fawcett J., Oquendo M., Tollefson G.D., Valuck R.J. & Tohen M. (2007Ecological studies of antidepressants and suicide risks. Harvard Review of Psychiatry 15, 133-145. (Pubitemid 47237774)
10. Baldessarini R.J., Vieta E., Calabrese J.R., Tohen M. & Bowden C. (in press). Bipolar depression: overview and commentary. Harvard Review of Psychiatry.
11. Barbui C., Esposito E. & Cipriani A. (2009). Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. Canadian Medical Association Journal 180, 291-297.
12. Bowden C.L., Calabrese J.R., Sachs G., Yatham L.N., Asghar A., Hompland M., Montgomery P., Earl N., Smoot T.M. & De VeaughGeiss J. (2003Placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Archives of General Psychiatry 60, 392-400. (Pubitemid 36403000)
13. Bschor T. & Bauer M. (2006Efficacy and mechanisms of action of lithium augmentation in refractory major depression. Current Pharmaceutical Design 12, 2985-2992. (Pubitemid 44184631)
14. Calabrese J.R., Bowden C.L., Sachs G., Yatham L.N., Behnke K., Mehtonen O.P., Montgomery P., Ascher J., Paska W., Earl N. & DeVeaugh-Geiss J. (2003Placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Journal of Clinical Psychiatry 64, 1013-1024. (Pubitemid 37158246)
15. Cipriani A., Pretty H., Hawton K. & Geddes J.R. (2005Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: Systematic review of randomized trials. American Journal of Psychiatry 162, 1805-1819. (Pubitemid 41428610)
16. Collins J.C. & McFarland B.H. (2008). Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. Journal of Affective Disorders 107, 23-28.
17. Dilsaver S.C., Chen Y.-W., Swann A.C., Shoaib A.M., Dilsaver Y.T. & Krajewski K.J. (1997). Suicidality panic disorder and psychosis in bipolar depression, depressive-mania and pure mania. Psychiatry Research 73, 47-56.
18. FDA (US Food and Drug Administration). (2007). Antidepressant use in children, adolescents, and adults. Retrieved February 18, 2009, from http://www.fda.gov/cder/drug/antidepressants/default.htm
19. Goldberg J.F., Perlis R.H., Bowden C.L., Thase M.E., Miklowitz D.J., Marangell L.B., Calabrese J.R., Nierenberg A.A. & Sachs G.S. (2009). Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. American Journal of Psychiatry 166, 173-181.
20. Goldsmith S.K., Pellmar T.C., Kleinman A.M. & Bunney W.E. (2002). Reducing Suicide. Institute of Medicine of the US National Academy of Science: Washington, DC.
21. Goodwin F.K., Fireman B., Simon G.E., Hunkeler E.M., Lee J. & Revicki D. (2003Suicide risk in bipolar disorder during treatment with lithium and divalproex. Journal of American Medical Association 290, 1467-1473. (Pubitemid 37430401)
22. Greil W., Ludwig-Mayerhofer W., Erazo N., Schochlin C., Schmidt S., Engel R.R., Czernik A., Giedke H., Müller-Oerlinghausen B., Osterheider M., Rudolf G.A., Sauer H., Tegeler J. & Wetterling T. (1997Lithium versus carbamazepine in the maintenance treatment of bipolar disorders: randomized study. Journal of Affective Disorders 43, 151-161. (Pubitemid 27219568)
23. Guzzetta F., Baldessarini R.J, Tondo L. & Centorrino F. (2007Lithium treatment and suicidal risk in recurrent unipolar major depression. Journal of Clinical Psychiatry 68, 380-383. (Pubitemid 46506801)
24. Hammad T.A., Laughren T.P. & Racoosin J.A. (2006). Suicide rates in short-term randomized controlled trials of newer antidepressants. Journal of Clinical Psychopharmacology 26, 203-207
25. Harris E.C. & Barraclough B. (1997Suicide as an outcome for mental disorders. a meta-analysis. British Journal of Psychiatry 170, 205-228. (Pubitemid 27117683)
26. Harris E.C. & Barraclough B. (1998). Excess mortality of mental disorder. British Journal of Psychiatry 173, 11-53.
27. Isometsä E.T., Henriksson M.M., Aro H.M., Heikkinen M.E., Kuoppasalmi K.I. & Lönnqvist J.K. (1994). Suicide in major depression. American Journal of Psychiatry 151, 530-536.
28. Joffe R.T., MacQueen G.M., Marriott M. & Trevor Young L. (2004Prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or bipolar II disorders. Bipolar Disorders 6, 62-66. (Pubitemid 38256505)
29. Judd L.L., Akiskal H.S., Schettler R.I., Endicott J., Maser J., Solomon D.A., Leon A.C., Rice J.A. & Keller M.B. (2002The longterm natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry 59, 530-537. (Pubitemid 34602935)
30. Kessing L.V., Søndergard L., Kvist K. & Andersen PK. (2005Suicide risk in patients treated with lithium. Archives of General Psychiatry 62, 860-866. (Pubitemid 41126880)
31. Kessler R.C., Berglund P., Borges G., Nock M. & Wang P.S. (2005Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. Journal of American Medical Association 293, 2487-2495. (Pubitemid 40705730)
32. Koukopoulos A. & Koukopoulos A. (1999). Agitated depression as a mixed state and the problem of melancholia. Psychiatric; Clinics of North America 22, 547-564.
33. Maj M., Pirozzi R., Magliano L., Fiorillo A. & Bartoli L. (2006). Agitated "unipolar" major depression: prevalence, phenomenology, and outcome. Journal of Clinical Psychiatry 67, 712-719.
34. Meltzer H.Y., Alphs L., Green A.I., Altamura A.C., Anand R., Bertoldi A., Bourgeois M., Chouinard G., Islam M.Z., Kane J., Krishnan R., Lindenmayer J.R, Potkin S. & International Suicide Prevention Trial Study Group. (2003). Clozapine treatment for suici-dality in schizophrenia: International Suicide Prevention Trial (InterSePT). Archives of General Psychiatry 60, 82-91.
35. Müller-Oerlinghausen B. (2001). Arguments for the specificity of the antisuicidal effect of lithium. European Archives of Psychiatry and Clinical Neuroscience 251, Suppl. 2, 72-75.
36. Muller-Oerlinghausen B., Ahrens B. & Felber W. (2006). The suicide-preventive and mortality-reducing effect of lithium. In Lithium in Neuropsychiatry (ed. M. Bauer., P. Grof, B. Muller-Oerlinghausen), pp 179-192. Informa Healthcare: London.
37. O'Donovan C., Garnham J.S., Hajek T. & Alda M. (2008Antidepressant monotherapy in pre-bipolar depression: predictive value and inherent risk. Journal of Affective Disorders 107, 293-298. (Pubitemid 351297780)
38. Oquendo M.A., Chaudhury S.R. & Mann J.J. (2005Pharmacotherapy of suicidal behavior in bipolar disorder. Archives of Suicide Research 9, 237-250. (Pubitemid 40977545)
39. Post R.M., Denicoff K.D., Leverich G.S., Altshuler L.L., Frye M.A., Suppes T.M., Rush A.J., Keck P.E. Jr., McElroy S.L., Luckenbaugh D.A., Poilio C., Kupka R. & Nolen W.A. (2003). Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. Journal of Clinical Psychiatry 64, 680-690.
40. Rihmer Z. & Pestality P. (1999). Bipolar II disorder and suicidal behavior. Psychiatric Clinics of Nord America 22, 667-673.
41. Roy A. (2001). Suicide. In Kaplan and Sadock's Comprehensive Textbook of Psychiatry (ed. B.J. Sadock and V.A. Sadock), pp. 2031-2040. Lippincott-Williams & Wilkins: Philadelphia.
42. Simon R.I., Hales R.E. (2006). Textbook of Suicide Assessment and Management. American Psychiatric Press: Washington, DC.
43. Thies-Flechtner K., Muller-Oerlinghausen B., Seibert W., Walther A. & Greil W. (1996Effect of prophylactic treatment on suicide risk in patients with major affective disorders: Data from a randomized prospective trial. Pharmacopsychiatry 29, 103-107. (Pubitemid 26150435)
44. Tondo L. & Baldessarini RJ. (2007Suicidal risks among 2826 Sardinian major affective disorder patients. Acta Psychtatrtca Scandinavica 116, 419-428. (Pubitemid 350086143)
45. Tondo L., Baldessarini R.J., Hennen J, Floris G., Silvetti F. & Tohen M. (1998Lithium treatment and risk of suicidal behavior in bipolar disorder patients. Journal of Clinical Psychiatry 59, 405-414. (Pubitemid 28391562)
46. Tondo L, Hennen J. & Baldessarini R.J. (2001Reduced suicide risk with long-term lithium treatment in major affective Illness: A metaanalysis. Acta Psychtatrtca Scandtnavlca 104, 163-172. (Pubitemid 32762270)
47. Tondo L., Isacsson G. & Baldessarini R.J. (2003Suicide in bipolar disorder: risk and prevention. CNS Drugs 17, 491-511. (Pubitemid 36693704)
48. Tondo L., Albert M.J. & Baldessarini R.J. (2006Suicide rates in relations to health care access in the United States: an ecological study. Journal of Clinical Psychiatry 67, 517-523. (Pubitemid 43764228)
49. Waddington D. & McKensie I.P. (1994Overdose rates in lithiumtreated vs. antidepressant-treated outpatients. Acta Psychtatrtca Scandinavica 90, 50-52. (Pubitemid 24212174)
50. Yerevanian B.I., Koek R.J. & Mintz J. (2003Lithium, anticonvulsants and suicidal behavior in bipolar disorder. Journal of Affective Disorders 73, 223-228. (Pubitemid 36120732)
51. Zisook S., Trivedi M.H., Warden D., Lebowitz B., Thase M.E., Stewart J.W., Montier C., Fava M., Wisniewski S.R., Luther J. & Rush AJ. (2009). Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: An examination of Citalopram in the STAR-D study. Journal of Affective Disorders, Epub ahead of print.